Therapeutic Options in High-risk Non-muscle-invasive Bladder Cancer During the Current Worldwide Shortage of Bacille Calmette-Guerin

被引：61
|
作者：
Mostafid, A. Hugh [1 ]
Palou Redorta, Joan [2 ]
Sylvester, Richard [3 ]
Witjes, J. Alfred [4 ]
机构：
[1] Royal Surrey Cty Hosp, Dept Urol, Guildford, Surrey, England
[2] Univ Autonoma Barcelona, Dept Urol, Fundacio Puigvert, E-08193 Barcelona, Spain
[3] European Org Res Treatment Canc, Brussels, Belgium
[4] Radboud UMC, Dept Urol, Nijmegen, Netherlands
来源：
EUROPEAN UROLOGY | 2015年 / 67卷 / 03期
关键词：
TRANSITIONAL-CELL CARCINOMA; IMMUNOTHERAPY; MAINTENANCE; T1; TA;
D O I：
10.1016/j.eururo.2014.11.031
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：359 / 360
页数：2
相关论文
共 50 条
  • [31] ADAPT and Improvise: Overcoming Bacillus Calmette-Guerin Unresponsiveness in Non-muscle-invasive Bladder Cancer
    Maitre, Priyamvada
    Sangar, Vijay
    Choudhury, Ananya
    EUROPEAN UROLOGY, 2023, 83 (06) : 495 - 496
  • [32] The Correct Sequence of Intravesical Chemotherapy and Bacillus Calmette-Guerin for Non-Muscle-invasive Bladder Cancer
    Oosterlinck, Willem
    Decaestecker, Karel
    EUROPEAN UROLOGY, 2015, 67 (03) : 517 - 518
  • [33] Can bacillus Calmette-Guerin immunotherapy prevent progression in non-muscle-invasive bladder cancer?
    Fujii, Yasuhisa
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (05) : 441 - 441
  • [34] Bacillus Calmette-Guerin (BCG) unresponsive non-muscle-invasive bladder cancer: are the subgroups equal?
    Tan, Wei Shen
    Grajales, Valentina
    Bree, Kelly
    Li, Roger
    Nogueras-Gonzalez, Graciela M.
    Navai, Neema
    Dinney, Colin
    Kamat, Ashish M.
    BJU INTERNATIONAL, 2023, 132 (04) : 384 - 386
  • [35] Prognostic significance of Bacillus Calmette-Guerin failure classification in non-muscle-invasive bladder cancer
    Shirakawa, Hiroshi
    Kikuchi, Eiji
    Tanaka, Nobuyuki
    Matsumoto, Kazuhiro
    Miyajima, Akira
    Nakamura, So
    Oya, Mototsugu
    BJU INTERNATIONAL, 2012, 110 (6B) : E216 - E221
  • [36] PROGNOSTIC SIGNIFICANCE OF BACILLUS CALMETTE-GUERIN FAILURE CLASSIFICATION IN NON-MUSCLE-INVASIVE BLADDER CANCER
    Singh, Bhupendra Pal
    Dhakad, Urmila
    BJU INTERNATIONAL, 2012, 110 (06) : E163 - E164
  • [37] Instillation Strategies for Non-Muscle-Invasive Bladder Cancer in the Bacillus Calmette-Guerin Shortage Era: A Simple Solution for BCG Discontinuation
    Lin, Po-Ting
    Hsieh, Ming-Li
    Su, Shih-Huan
    Chang, Ying-Hsu
    Huang, Liang-Kang
    Chu, Yuan-Cheng
    Kan, Hung-Cheng
    Lin, Po-Hung
    Yu, Kai-Jie
    Chuang, Cheng-Keng
    Wu, Chun-Te
    Pang, See-Tong
    Shao, I-Hung
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3121 - 3130
  • [38] Liquid Biopsy for Predicting Bacillus Calmette-Guerin Unresponsiveness in Non-muscle-invasive Bladder Cancer
    Nicolazzo, Chiara
    de Berardinis, Ettore
    Gazzaniga, Paola
    EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (01): : 124 - 125
  • [39] The Effectiveness of Bacillus Calmette-Guerin (BCG) Maintenance Treatment in Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
    Kim, B.
    Ha, J.
    Park, C.
    Kim, C.
    UROLOGY, 2012, 80 (03) : S215 - S216
  • [40] Partial Versus Complete Bacillus Calmette-Guerin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non-muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?
    Rezaee, Michael E.
    Ismail, A. Aziz Ould
    Okorie, Chiamaka L.
    Seigne, John D.
    Lynch, Kristine E.
    Schroeck, Florian R.
    EUROPEAN UROLOGY OPEN SCIENCE, 2021, 26 : 35 - 43
12345